查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1577507

心臟缺陷闭合装置的全球市场

Heart Defect Closure Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 177 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球心臟缺陷闭合装置市场预计将达到 66 亿美元

2023 年全球心臟缺陷闭合设备市场估计为 27 亿美元，预计到 2030 年将达到 66 亿美元，2023-2030 年分析期间复合年增长率为 13.5%。左心耳 (LAA) 封堵器是本报告分析的细分市场之一，预计复合年增长率为 14.4%，到分析期结束时将达到 35 亿美元。在分析期间，先天性心臟病 (CHD) 封堵器市场的复合年增长率预计为 12.9%。

美国市场预计将达到7.427亿美元，中国预计复合年增长率为18.2%。

预计 2023 年美国心臟缺陷闭合设备市场规模将达 7.427 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达15亿美元，2023-2030年分析期间复合年增长率为18.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 10.0% 和 11.8%。在欧洲，德国预计复合年增长率为 10.7%。

全球心臟缺陷封堵器市场—主要趋势与驱动因素总结

为什么心臟缺陷闭合装置对于心血管健康管理至关重要？

心臟缺陷闭合装置是治疗结构性心臟异常的重要工具，提供了一种微创解决方案，可显着降低先天性和后天性心臟缺陷相关的风险。这些设备主要用于治疗心房中膈缺损症(ASD)、卵圆孔未闭合(PFO) 和室间隔缺损 (VSD) 等疾病，如果不及时治疗，所有这些疾病都会损害正常的心臟功能，从而导致併发症。如中风、心臟衰竭和心律不整。传统上，此类缺陷需要进行心臟直视手术，但心臟直视手术併发症风险很高，并且需要很长的恢復时间。然而，心臟缺陷闭合装置提供了一种侵入性较小的替代方案，允许心臟科医师使用基于导管的手术来闭合此类缺陷。这种方法不仅可以最大限度地减少创伤，而且可以缩短恢復时间，使其成为儿童和成人患者的首选。这些设备能够提供安全有效的治疗结果，从而改变了治疗格局，减少了对复杂手术介入的需求，并使心臟缺陷管理变得更加容易。因此，这些设备已成为现代心血管治疗的基石，并且不断进步，扩大其适应症并提高其手术效率。

塑造心臟缺陷封堵器市场的主要趋势和技术进步是什么？

由于不断变化的临床需求、技术创新以及对以患者为中心的护理的关注，心臟缺陷闭合设备市场正在快速发展。最显着的趋势之一是下一代生物可吸收装置的开发。该装置提供临时支撑，不需要永久植入，因为一旦缺损闭合，它就会逐渐溶解。这种生物可吸收装置可减少长期併发症，例如装置腐蚀和对未来手术的干扰，从而提高患者安全和治疗效果。另一个重要趋势是仪器的小型化。这使得能够治疗较小的缺陷并扩大其在新生儿和儿科患者中的使用。这些小型、灵活的器械旨在更轻鬆地处理复杂的解剖结构，降低手术风险并提高年轻患者缺损闭合的成功率。此外，3D 超音波心动图和即时 MRI 等先进成像技术的整合透过在设备就位时提供心臟结构的详细可视化来提高手术的精确度。这对于复杂情况尤其有利，因为精确定位对于获得最佳结果非常重要。此外，人们越来越重视混合手术，结合基于导管的技术和外科技术来治疗多方面或高风险的缺陷。这种混合方法可以实现量身定制的治疗策略，并为以前被认为无法手术的患者提供新的可能性。这些趋势和创新不仅扩大了心臟缺陷闭合装置的功能，而且正在重塑先天性和结构性心臟疾病治疗的临床方法。

技术创新如何提高心臟缺陷闭合装置的性能和安全性？

技术创新在提高心臟缺损闭合装置的性能、安全性和多功能性方面发挥着至关重要的作用，解决了与传统方法相关的一些长期挑战。最重要的进步之一是镍钛合金等新材料的使用。镍钛诺提供卓越的柔韧性和形状记忆，使其能够更有效地贴合心臟的轮廓。镍钛诺的生物相容性也最大限度地降低了副作用的风险，并促进与心臟组织的整合。此外，正在探索使用生物可吸收聚合物来提供临时支架并创建随着时间的推移而无害降解的装置，以减少长期併发症的风险和二次手术的需要，数量正在增加。另一个突破是采用涂层技术，提高了设备的血液相容性，降低了血栓形成的风险，并减少了长期抗凝血治疗的需要。此外，即时影像集成，例如血管内超音波(IVUS) 和 3D 测绘系统的使用，可显着提高临床医生放置设备的精度，确保准确放置并最大程度地消除程序错误。远端控制和机器人辅助系统的发展进一步提高了可操作性和稳定性，使手术更加安全，特别是在复杂的解剖环境中。这些进步不仅使手术变得更安全、更有效，而且为最困难病例的广泛采用铺平了道路，并改善了先天性和结构性心臟疾病患者的整体治疗。

是什么推动了心臟闭合装置市场的成长？

心臟缺陷闭合装置市场的成长是由几个因素推动的，这些因素主要受先天性心臟缺陷盛行率的增加、微创技术的进步以及对早期疗育选择的认识不断增强的影响。主要成长要素之一是全球先天性心臟异常发生率的上升，这增加了对安全有效治疗方案的需求。诊断技术的进步，例如在产前诊断中使用高解析度影像，可以及早发现心臟异常，从而增加适合接受闭合手术的患者数量。此外，人们越来越倾向于微创心臟治疗，与传统的心臟直视手术相比，微创心臟治疗有望缩短恢復时间，降低併发症发生率并提高患者满意度，这将显着推动市场成长。另一个重要因素是儿科族群越来越多地采用基于导管的手术。这是由于年轻患者需要安全、有效且侵入性较小的解决方案而推动的。专用儿科设备的日益普及为新生儿和婴幼儿患者开闢了新的治疗可能性，这些患者通常面临独特的解剖学和临床挑战。此外，新兴市场医疗保健支出的增加和心臟专科医疗中心的扩张正在为采用这些先进治疗设备创造新的机会。随着具有增强安全性和扩大适应症的新设备被引入市场，主要市场参与企业对研发的持续投资也有助于成长。心臟缺陷闭合设备在更广泛的心血管设备产业中迅速扩张，有利的报销政策和监管支持进一步推动了北美和欧洲等地区的采用。这些因素，再加上对以患者为中心的护理和长期结果的日益关注，确保心臟缺陷闭合设备始终处于创新心血管健康管理的前沿，并推动市场向前发展。

受访企业范例（总合36 家知名企业）

  • Abbott Cardiovascular
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Encore Medical
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Lifetech Scientific Corporation
  • Meril Life Sciences Pvt., Ltd.
  • MicroPort Scientific Corporation
  • Occlutech US LLC
  • Sahajanand Medical Technologies Pvt., Ltd.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP24300

Global Heart Defect Closure Devices Market to Reach US$6.6 Billion by 2030

The global market for Heart Defect Closure Devices estimated at US$2.7 Billion in the year 2023, is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 13.5% over the analysis period 2023-2030. Left Atrial Appendage (LAA) Closure Device, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$3.5 Billion by the end of the analysis period. Growth in the Congenital Heart Defect (CHD) Closure Device segment is estimated at 12.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$742.7 Million While China is Forecast to Grow at 18.2% CAGR

The Heart Defect Closure Devices market in the U.S. is estimated at US$742.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 18.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.0% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

Global Heart Defect Closure Devices Market - Key Trends and Drivers Summarized

Why Are Heart Defect Closure Devices Crucial in Cardiovascular Health Management?

Heart defect closure devices are critical tools in the treatment of structural heart anomalies, providing minimally invasive solutions that significantly reduce the risks associated with congenital and acquired heart defects. These devices are primarily used to treat conditions such as atrial septal defects (ASD), patent foramen ovale (PFO), and ventricular septal defects (VSD), all of which can impair normal cardiac function and lead to complications like stroke, heart failure, and arrhythmias if left untreated. Traditionally, such defects required open-heart surgery, which carries a high risk of complications and a prolonged recovery period. Heart defect closure devices, however, offer a less invasive alternative by allowing cardiologists to seal these defects using catheter-based procedures. This approach not only minimizes trauma but also enables faster recovery times, making it a preferred option for both pediatric and adult patients. The ability of these devices to deliver safe and effective outcomes has revolutionized the treatment landscape, reducing the need for complex surgical interventions and making heart defect management more accessible. As a result, these devices have become a cornerstone of modern cardiovascular care, with ongoing advancements aiming to expand their indications and improve procedural efficiency.

What Are the Key Trends and Technological Advancements Shaping the Heart Defect Closure Device Market?

The heart defect closure device market is witnessing rapid advancements, driven by a combination of evolving clinical needs, technological innovations, and increased focus on patient-centric care. One of the most prominent trends is the development of next-generation, bioresorbable devices that offer temporary support and gradually dissolve after the defect is closed, eliminating the need for permanent implants. These bioresorbable devices reduce long-term complications, such as device erosion and interference with future procedures, thereby enhancing patient safety and outcomes. Another significant trend is the miniaturization of devices, which is enabling the treatment of smaller defects and expanding their use in neonatal and pediatric patients. These smaller, more flexible devices are designed to navigate complex anatomies with greater ease, reducing procedural risks and improving the success rate of defect closure in younger populations. In addition, the integration of advanced imaging technologies, such as 3D echocardiography and real-time MRI, is enhancing procedural precision by providing detailed visualizations of the heart’s structure during device placement. This is particularly beneficial for complex cases where precise positioning is critical for optimal outcomes. Furthermore, there is a growing emphasis on hybrid procedures that combine catheter-based and surgical techniques to treat multi-faceted or high-risk defects. These hybrid approaches allow for tailored treatment strategies, offering new possibilities for patients who were previously considered inoperable. Collectively, these trends and innovations are not only expanding the capabilities of heart defect closure devices but are also reshaping the clinical approach to congenital and structural heart defect management.

How Are Technological Innovations Improving the Performance and Safety of Heart Defect Closure Devices?

Technological innovations are playing a pivotal role in enhancing the performance, safety, and versatility of heart defect closure devices, addressing some of the longstanding challenges associated with traditional approaches. One of the most significant advancements is the use of new materials, such as nitinol, which offer superior flexibility and shape memory, allowing devices to conform more effectively to the contours of the heart. Nitinol’s biocompatibility also minimizes the risk of adverse reactions and promotes better integration with the cardiac tissue. Additionally, bioresorbable polymers are being increasingly utilized to create devices that provide temporary scaffolding and then degrade harmlessly over time, reducing the risk of long-term complications and the need for secondary procedures. Another breakthrough is the incorporation of coating technologies that enhance the hemocompatibility of devices, reducing the risk of thrombus formation and the need for long-term anticoagulation therapy. Moreover, real-time imaging integration, such as the use of intravascular ultrasound (IVUS) and 3D mapping systems, is providing clinicians with unparalleled accuracy during device deployment, ensuring precise placement and minimizing procedural errors. The development of remote-controlled and robotic-assisted systems is further improving procedural safety by offering enhanced maneuverability and stability, especially in complex anatomical settings. These advancements are not only making heart defect closure devices safer and more effective but are also paving the way for broader adoption in challenging cases, thereby improving the overall treatment landscape for patients with congenital and structural heart defects.

What Is Driving the Growth of the Heart Defect Closure Device Market?

The growth in the heart defect closure device market is driven by several factors, primarily influenced by increasing prevalence of congenital heart defects, advancements in minimally invasive technologies, and growing awareness of early intervention options. One of the main growth drivers is the rising incidence of congenital heart anomalies globally, which is leading to greater demand for safe and effective treatment options. Advances in diagnostic techniques, such as the use of high-resolution imaging in prenatal care, are enabling earlier detection of heart defects, thereby increasing the number of patients eligible for closure procedures. Additionally, the ongoing shift towards minimally invasive cardiac interventions is significantly boosting market growth, as these procedures offer reduced recovery times, lower complication rates, and improved patient satisfaction compared to traditional open-heart surgeries. Another critical factor is the growing adoption of catheter-based techniques in pediatric populations, driven by the need for safe, effective, and less invasive solutions for younger patients. The increasing availability of specialized pediatric devices is opening up new treatment possibilities for neonatal and infant patients, who often present unique anatomical and clinical challenges. Furthermore, rising healthcare expenditure and the expansion of specialized cardiac care centers in emerging markets are creating new opportunities for the adoption of these advanced therapeutic devices. The continuous investment in research and development by key market players is also contributing to the growth, as new devices with enhanced safety features and broader indications enter the market. Favorable reimbursement policies and regulatory support in regions like North America and Europe are further driving adoption, making heart defect closure devices a rapidly expanding segment within the broader cardiovascular device industry. These factors, combined with the growing focus on patient-centric care and long-term outcomes, are propelling the market forward, ensuring that heart defect closure devices remain at the forefront of innovative cardiovascular health management.

Select Competitors (Total 36 Featured) -

  • Abbott Cardiovascular
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Encore Medical
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Lifetech Scientific Corporation
  • Meril Life Sciences Pvt., Ltd.
  • MicroPort Scientific Corporation
  • Occlutech US LLC
  • Sahajanand Medical Technologies Pvt., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Heart Defect Closure Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Congenital Heart Defects Drives Demand for Heart Defect Closure Devices
    • Here's the Story: How Growing Adoption of Minimally Invasive Procedures Expands the Addressable Market for Non-Surgical Closure Devices
    • Increasing Focus on Pediatric Cardiac Care Propels Market Growth for Advanced Closure Solutions
    • Advancements in Device Design and Materials Strengthen the Business Case for Next-Generation Heart Defect Closure Devices
    • Here's How the Shift Towards Catheter-Based Interventions Generates Opportunities for Transcatheter Closure Devices
    • Expansion of Hybrid Cardiac Procedures Transforms Market Dynamics by Offering Combined Surgical and Transcatheter Solutions
    • Emphasis on Reducing Recovery Time and Post-Operative Complications Sustains Demand for Minimally Invasive Devices
    • Growing Use of Imaging Technologies Enhances Precision in Device Placement and Improves Surgical Outcomes
    • Here's How Rising Adoption of Wearable Health Monitors Spurs Growth in Demand for Early Intervention Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Heart Defect Closure Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Heart Defect Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Left Atrial Appendage (LAA) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Left Atrial Appendage (LAA) Closure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Congenital Heart Defect (CHD) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Congenital Heart Defect (CHD) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Congenital Heart Defect (CHD) Closure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Patent Foramen Ovale (PFO) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Patent Foramen Ovale (PFO) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Patent Foramen Ovale (PFO) Closure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • JAPAN
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • CHINA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • EUROPE
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Heart Defect Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • FRANCE
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • GERMANY
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Heart Defect Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • INDIA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Heart Defect Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Heart Defect Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • AFRICA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030

IV. COMPETITION